0001415889-24-016341.txt : 20240611
0001415889-24-016341.hdr.sgml : 20240611
20240611160007
ACCESSION NUMBER: 0001415889-24-016341
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240610
FILED AS OF DATE: 20240611
DATE AS OF CHANGE: 20240611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LILLY ENDOWMENT INC
CENTRAL INDEX KEY: 0000316011
ORGANIZATION NAME:
STATE OF INCORPORATION: IN
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06351
FILM NUMBER: 241035684
BUSINESS ADDRESS:
STREET 1: 2801 NORTH MERIDIAN STREET
CITY: INDIANANAPOLIS
STATE: IN
ZIP: 46208
BUSINESS PHONE: 3179245471
MAIL ADDRESS:
STREET 1: 2801 NORTH MERIDIAN ST
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46208
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ELI LILLY & Co
CENTRAL INDEX KEY: 0000059478
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 350470950
STATE OF INCORPORATION: IN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: LILLY CORPORATE CTR
STREET 2: DROP CODE 1094
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
BUSINESS PHONE: 3172762000
MAIL ADDRESS:
STREET 1: LILLY CORPORATE CENTER
STREET 2: DROP CODE 1094
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
FORMER COMPANY:
FORMER CONFORMED NAME: LILLY ELI & CO
DATE OF NAME CHANGE: 19941024
4
1
form4-06112024_040603.xml
X0508
4
2024-06-10
0000059478
ELI LILLY & Co
LLY
0000316011
LILLY ENDOWMENT INC
2801 NORTH MERIDIAN STREET
INDIANAPOLIS
IN
46208-0068
false
false
true
false
0
Common Stock
2024-06-10
4
S
0
2300
851.688
D
97867020
D
Common Stock
2024-06-10
4
S
0
400
852.36
D
97866620
D
Common Stock
2024-06-10
4
S
0
2313
854.212
D
97864307
D
Common Stock
2024-06-10
4
S
0
3837
855.561
D
97860470
D
Common Stock
2024-06-10
4
S
0
6267
856.673
D
97854203
D
Common Stock
2024-06-10
4
S
0
5879
857.668
D
97848324
D
Common Stock
2024-06-10
4
S
0
8835
858.723
D
97839489
D
Common Stock
2024-06-10
4
S
0
9001
859.487
D
97830488
D
Common Stock
2024-06-10
4
S
0
8374
860.713
D
97822114
D
Common Stock
2024-06-10
4
S
0
954
861.435
D
97821160
D
Common Stock
2024-06-10
4
S
0
3600
862.827
D
97817560
D
Common Stock
2024-06-10
4
S
0
759
863.814
D
97816801
D
Common Stock
2024-06-10
4
S
0
13415
865.061
D
97803386
D
Common Stock
2024-06-10
4
S
0
1780
865.888
D
97801606
D
Common Stock
2024-06-10
4
S
0
3117
867.032
D
97798489
D
Common Stock
2024-06-10
4
S
0
2600
868.206
D
97795889
D
Common Stock
2024-06-10
4
S
0
1500
869.215
D
97794389
D
Common Stock
2024-06-10
4
S
0
579
870.13
D
97793810
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $851.19 to $852.09, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), and (17) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $853.98 to $854.71, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $855.00 to $855.97, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $856.11 to $857.10, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $857.11 to $858.10, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $858.12 to $859.11, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $859.14 to $860.13, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $860.15 to $861.14, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $861.19 to $861.68, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $862.26 to $863.23, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $863.3625 to $864.3128, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $864.4721 to $865.40, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $865.5651 to $866.14, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $866.69 to $867.37, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $867.72 to $868.6802, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $868.7528 to $869.748, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $869.7693 to $870.74, inclusive.
/s/ Diane M. Stenson, Vice President and Treasurer, on behalf of Lilly Endowment Inc.
2024-06-11